PhD students, Charlotte Criscuolo, Rebecca Kelly, Michael Eyres and Tim Muntslag – who are currently undertaking 4-6 month MRC-funded placements at MDC, sat down with MDC’s Chief Scientific Officer, Professor Peter Simpson and Chief Informatics Officer, Professor John P. Overington for the discussion.
To celebrate British Science Week, Medicines Discovery Catapult have brought their most experienced scientists together with their newest scientists to talk about their motivations to get into drug discovery, as well as the future of the field.
PhD students, Charlotte Criscuolo, Rebecca Kelly, Michael Eyres and Tim Muntslag – who are currently undertaking 4-6 month MRC-funded placements at MDC, sat down with MDC’s Chief Scientific Officer, Professor Peter Simpson and Chief Informatics Officer, Professor John P. Overington for the discussion.
Find out more about the cohort of MRC-funded PhD students that have joined MDC as part of a training, talent and skills agenda, to help develop the next generation of drug discovery researchers here.
PACE (Pathways to Antimicrobial Clinical Efficacy) and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns.
New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs.
